Asus unveils the VivoWatch 6 Plus, integrating ECG and blood pressure monitoring into a wearable with a custom SoC, but its true impact lies in how it bridges healthcare and AI ecosystems.
The Sensor Suite: ECG and BP Monitoring Under the Hood
The VivoWatch 6 Plus deploys a dual-mode ECG sensor using a 3-lead configuration, a step up from the single-lead systems in competitors like the Apple Watch. This architecture enables more accurate atrial fibrillation detection, though it still lacks the precision of clinical-grade devices. Blood pressure monitoring relies on a photoplethysmography (PPG) array paired with a proprietary algorithm, a method criticized by cardiologists for its inconsistency compared to oscillometric cuffs. A 2020 study found PPG-based BP estimates vary by ±10 mmHg, a limitation Asus hasn’t addressed in its specs. The device’s sensor array sits atop a 5nm ARM Cortex-M55 core, part of Asus’s custom “VitaCore” SoC, which prioritizes low-power signal processing. This design reduces thermal throttling but limits computational headroom for on-device AI models.
The 30-Second Verdict
Health monitoring is more aspirational than actionable; the VitaCore SoC hints at future AI integration, but current capabilities remain basic.
Ecosystem Implications: Open vs. Closed Systems
Asus’s decision to use a proprietary SoC for health data processing creates a walled garden, complicating third-party app development. While the watch supports BLE 5.3 and NFC, its health data API is restricted to Asus’s own health platform, VivoHealth. This contrasts with Apple’s HealthKit, which allows cross-platform interoperability. A
“Asus is doubling down on vertical integration, but this risks alienating developers who prefer open ecosystems,”
says Dr. Raj Patel, a wearable tech analyst at MIT Media Lab. “The VitaCore’s lack of public SDKs means most innovation will occur within Asus’s silo.” The device also leverages Google’s Wear OS 5, but with heavy customization. This hybrid approach creates friction: users gain access to Google’s app ecosystem, but critical health data remains trapped in Asus’s proprietary stack.
What This Means for Enterprise IT
Companies adopting the VivoWatch 6 Plus for employee wellness programs may face compatibility challenges. Data export options are limited and compliance with HIPAA remains unverified.
The AI-Healthcare Feedback Loop
Asus positions the VivoWatch 6 Plus as a “predictive health hub,” but its AI capabilities are confined to basic anomaly detection. The SoC includes a 1.2TOPS NPU, sufficient for on-device ECG analysis but not for advanced machine learning tasks. A Google Health paper from 2025 highlights the risks of underpowered edge AI: “Without sufficient compute, models cannot adapt to individual user metrics, leading to false positives.” Asus’s reliance on cloud-based processing for complex analysis further raises privacy concerns. The watch’s “Health IQ” feature, which uses LLMs to interpret biometric trends, is reportedly trained on a closed dataset. This limits its utility for users with rare medical conditions, as noted by
“The model’s training data lacks diversity, making it less effective for non-Caucasian populations,”
warns Dr. Lena Chen, a biomedical engineer at Stanford.
Thermal Design and Battery Life: The Unseen Trade-Off
Despite the VitaCore’s efficiency, the VivoWatch 6 Plus suffers from thermal throttling during prolonged ECG sessions. Benchmarks from AnandTech show a 15% performance drop after 30 minutes of continuous monitoring, a critical flaw for medical-grade devices. Battery life claims of 7 days under mixed use align with industry norms, but heavy sensor usage reduces this to 3-4 days. Repairability is low: the device uses proprietary screws and a glued display, making DIY fixes impractical.
The 30-Second Verdict
Thermal management and repairability issues undermine its premium positioning. The AI features are underwhelming, and the ecosystem lock-in stifles innovation.
Market Positioning and Competitive Landscape
The VivoWatch 6 Plus targets health-conscious consumers priced at $399, competing with the Fitbit Sense 2 and Garmin Venu 3. Its ECG feature is a unique selling point, but the absence of a built-in ECG app in many regions (due to regulatory delays) weakens its appeal. Asus’s broader AI strategy, unveiled at COMPUTEX 2026, includes the RUC-2000-Series edge AI systems. These could eventually feed data into the VivoWatch, creating a seamless health analytics pipeline
